KR20080037857A - Non hydrous cosmetic compositions of bubbling pill type containing hydrophilic active ingredients - Google Patents

Non hydrous cosmetic compositions of bubbling pill type containing hydrophilic active ingredients Download PDF

Info

Publication number
KR20080037857A
KR20080037857A KR1020060105078A KR20060105078A KR20080037857A KR 20080037857 A KR20080037857 A KR 20080037857A KR 1020060105078 A KR1020060105078 A KR 1020060105078A KR 20060105078 A KR20060105078 A KR 20060105078A KR 20080037857 A KR20080037857 A KR 20080037857A
Authority
KR
South Korea
Prior art keywords
acid
active ingredients
bubbling
weight
water
Prior art date
Application number
KR1020060105078A
Other languages
Korean (ko)
Other versions
KR101230934B1 (en
Inventor
박창훈
권이경
한상훈
송현려
강학희
Original Assignee
(주)아모레퍼시픽
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)아모레퍼시픽 filed Critical (주)아모레퍼시픽
Priority to KR1020060105078A priority Critical patent/KR101230934B1/en
Publication of KR20080037857A publication Critical patent/KR20080037857A/en
Application granted granted Critical
Publication of KR101230934B1 publication Critical patent/KR101230934B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216Solid or semisolid forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • A61K8/355Quinones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • A61K8/675Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01DCOMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
    • C01D7/00Carbonates of sodium, potassium or alkali metals in general
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/22Gas releasing
    • A61K2800/222Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

Bubbling pill type of anhydrous cosmetic compositions containing hydrophilic active ingredients are provided to stabilize active ingredients, induce voluntary solubilization of the active ingredients in the presence of water, and conveniently observe the solubilization finish time visually. A bubbling pill type of anhydrous cosmetic composition contains 1.0-60.0 wt.% of hydrophilic active ingredients including vitamin C(ascorbic acid), kojic acid, arbutin, niacinamide and acetyl glucosamine, 5.0-70.0 wt.% of sodium carbonate or sodium bicarbonate, 1.0-70.0 wt.% of alpha-hydroxy acid selected from malic acid, lactic acid, glycolic acid and citric acid and 5.0-30.0 wt.% of polyethylene glycol.

Description

수용성 활성성분을 함유하는 발포형 알약 형태의 무수 제형의 화장료 조성물 {Non hydrous cosmetic compositions of bubbling pill type containing hydrophilic active ingredients} Non-hydrous cosmetic compositions of bubbling pill type containing hydrophilic active ingredients

본 발명은 수용성 활성성분을 함유하는 발포형(버블링, bubbling) 알약(필, pill) 형태의 무수 제형의 화장료 조성물에 관한 것으로, 보다 상세하게는 비타민C, 코지산, 알부틴과 같은 불안정한 수용성 활성성분을 발포형 알약 형태로 만듦으로써 활성성분을 안정화시킬 수 있는 발포형 알약 형태의 무수 제형의 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition of anhydrous formulations in the form of foamed (bubbling) pills (pills) containing water-soluble active ingredients, more particularly unstable water-soluble activity such as vitamin C, kojic acid, arbutin The present invention relates to a cosmetic composition of the anhydrous formulation in the form of a foamed pill which can stabilize the active ingredient by making the component in the form of a foamed pill.

피부에 여러 가지 효과를 주는 화장품 원료 중에 미백이나 주름 개선 효과를 주는 성분들은 일반적으로 불안정한 성분으로 알려진 것들이 많다. 예를 들면 비타민C, 코지산, 알부틴 등이 있다. 그 중에서 비타민C는 미백, 주름 개선, 황산화 효과가 우수한 성분으로 알려져 있으나, 매우 불안정한 것으로 알려진 대표적인 성분이다. 따라서 화장품 기술자들은 이러한 효과가 우수한 성분을 화장품에 사용하고자 안정화시키는 방법을 시도하였다. Among cosmetic ingredients that have various effects on the skin, whitening and antiwrinkle ingredients are generally known as unstable ingredients. Examples include vitamin C, kojic acid, and arbutin. Among them, vitamin C is known as an excellent ingredient for whitening, wrinkle improvement, and sulfated effect, but is a representative component known to be very unstable. Therefore, cosmetic technicians have tried to stabilize the ingredients for use in cosmetics that have excellent effects.

물이 있는 환경에서는 비타민C가 변색이 되기 쉽다. 그래서 주로 P/S(polyol in silicone)제형을 이용하여 폴리올 상에 비타민 C를 넣어서 에멀젼 형태로 안정화시키거나 오일 상에 비타민 C를 넣고 점증시키는 방법을 이용하였다. 폴리올에 비타민C를 넣을 경우 비타민C가 어느 정도 안정화되기는 하지만 폴리올에 함유되어 있는 수분에 의해 고온에서 변색이 일어나게 되며, 폴리올이 흡습성을 띄게 되는 경우에도 변색이 일어나게 되는 문제점이 있다. 오일에 비타민C를 혼합하여 점증을 시키는 경우는 외부에서의 수분공급을 차단하게 되어 비타민C를 안정화시킬 수는 있지만, 화장품으로서의 사용감은 매우 나빠지게 되는 단점이 있다. 또 다른 안정화 방법으로는 여러 가지 성분들을 파우더 형태로 단순 혼합하여 사용 시에만 에센스의 용액과 섞어서 사용하는 방법이 있다. 이 경우에는 파우더 형태를 에센스에 넣고 흔들어주어야 하는 불편함이 따르게 된다. 또한, 파우더 형태와 에센스가 내장된 부분이 얇은 막으로 경계를 이루는 용기를 이용할 경우, 이 경계막이 약하여 충격에 깨지면 에센스 액이 흘러 들어와서 비타민C의 변색이 일어날 수 있다는 문제점이 있다. Vitamin C tends to discolor in water. So, mainly using P / S (polyol in silicone) formulation to put vitamin C on the polyol to stabilize in emulsion form or to add vitamin C on the oil was used. When vitamin C is added to the polyol, the vitamin C is stabilized to some extent, but discoloration occurs at a high temperature due to moisture contained in the polyol, and there is a problem that discoloration occurs even when the polyol exhibits hygroscopicity. In the case of increasing the mixing of vitamin C in the oil, it is possible to stabilize the vitamin C by blocking the water supply from the outside, but there is a disadvantage that the feeling as a cosmetic becomes very bad. Another stabilization method involves simply mixing various ingredients in powder form and mixing them with the solution of the essence. In this case, the inconvenience of having to shake the powder form into the essence. In addition, when using a container in which the powder form and the essence built-in part is bounded by a thin film, there is a problem that the boundary film is weak and breaks in the impact, so that the essence liquid may flow in and discolor the vitamin C.

이에 본 발명자들은 소듐 카보네이트(sodium carbonate) 또는 소듐 바이카보네이트(sodium bicarbonate)와 알파 하이드록시산(α-hydroxy acid)을 이용하여 발포형 알약 형태의 무수 제형을 적용함으로써 상기의 문제를 해결할 수 있었다. 뿐만 아니라 사용시 수용성 활성물질의 용해 완료시점을 직접 눈으로 확인할 수 있 고, 버블링 현상에 의한 재미를 소비자에게 줄 수 있으며, 투입하는 입자의 개수를 조절함으로써 유액내의 수용성 물질의 농도를 직접 조절할 수 있는 새로운 제형을 발견하고 본 발명을 완성하였다. The present inventors have been able to solve the above problem by applying anhydrous formulations in the form of effervescent tablets using sodium carbonate or sodium bicarbonate and alpha hydroxy acid. In addition, it is possible to check the completion time of dissolving the water-soluble active substance by using it directly, to give consumers the fun by the bubbling phenomenon, and to directly control the concentration of the water-soluble substance in the emulsion by controlling the number of particles to be injected. New formulations were discovered and the present invention was completed.

따라서 본 발명의 목적은 불안정한 수용성 활성물질을 안정화시키고, 물이 있는 환경에서 활성 성분의 용해가 자발적으로 일어나며, 용해 완료시점을 쉽게 확인할 수 있는 편리성을 주는 발포형 알약 형태의 무수 제형의 화장료 조성물을 제공하는 것이다. Accordingly, an object of the present invention is to stabilize the unstable water-soluble active substance, the dissolution of the active ingredient spontaneously occurs in the water environment, the cosmetic composition of the anhydrous formulation in the form of an effervescent pill form that gives the convenience to easily confirm the completion point of the dissolution To provide.

상기한 목적을 달성하기 위하여 본 발명에 따른 화장료 조성물은 수용성 활성성분; 소듐 카보네이트(sodium carbonate) 또는 소듐 바이카보네이트(sodium bicarbonate); 알파 하이드록시산(α-hydroxy acid); 및 폴리에틸렌글리콜(PEG 150)을 함유한다.Cosmetic composition according to the present invention to achieve the above object is a water-soluble active ingredient; Sodium carbonate or sodium bicarbonate; Alpha hydroxy acid; And polyethylene glycol (PEG 150).

상기 조성물 총 중량에 대하여 수용성 활성성분은 1.0~60.0 중량%, 소듐 카보네이트 또는 소듐 바이카보네이트는 5.0∼70.0 중량%, 알파 하이드록시산은 1.0∼70.0 중량%, 폴리에틸렌글리콜은 5.0∼30.0 중량%를 함유하는 것이 바람직하다.The total weight of the composition contains 1.0 to 60.0% by weight of water-soluble active ingredient, 5.0 to 70.0% by weight of sodium carbonate or sodium bicarbonate, 1.0 to 70.0% by weight of alpha hydroxy acid, and 5.0 to 30.0% by weight of polyethylene glycol. It is preferable.

한편, 상기 수용성 활성성분은 비타민C(ascorbic acid), 코지산(kojic acid), 알부틴(arbutin), 니아신아미드(niacinamide) 및 아세틸글루코스아민(acetyl glucosamine) 로 이루어진 군에서 선택된 1종 이상임을 특징으로 하지만, 이에 한정하는 것은 아니다. On the other hand, the water-soluble active ingredient is characterized in that at least one selected from the group consisting of vitamin C (ascorbic acid), kojic acid (kojic acid), arbutin (arbutin), niacinamide (acetylcinamide) and acetyl glucosamine (acetyl glucosamine) However, it is not limited thereto.

또한, 상기 알파 하이드록시산은 말릭산(malic acid), 락틱산(lactic acid), 글리콜릭산(glycolic acid) 및 시트릭산(citric acid)으로 이루어진 군에서 선택된 것임을 특징으로 하며, 바람직하게는 말릭산을 사용한다.In addition, the alpha hydroxy acid is characterized in that it is selected from the group consisting of malic acid (malic acid), lactic acid (lactic acid), glycolic acid (glycolic acid) and citric acid (citric acid), preferably malic acid use.

이하 본 발명을 보다 구체적으로 설명한다. Hereinafter, the present invention will be described in more detail.

본 발명의 화장료 조성물은 발포형의 알약 형태를 가지기 위해서 스킨, 로션, 크림 등과 같은 일반 화장료 조성물과는 다른 조성을 가지고 있다. 발포성질을 가지기 위해서 수용성 활성성분은 총 중량에 대해 1.0~60.0 중량%, 바람직하게는 10.0~40.0 중량% 범위로 배합한다. 소듐 카보네이트 또는 소듐 바이카보네이트는 총 중량에 대해 5.0∼70.0 중량%, 바람직하게는 20.0∼40.0 중량% 범위로 배합하며, 알파 하이드록시산은 총 중량에 대해 1.0∼70.0 중량%, 바람직하게는 20.0 ∼40.0 중량% 범위로 배합한다. 그리고 알약형태로 성형하기 위해서는 바인더로 폴리에틸렌글리콜은 총 중량에 대해 5.0∼30.0 중량%, 바람직하게는 10∼20 중량% 범위로 배합한다. The cosmetic composition of the present invention has a composition different from general cosmetic compositions such as skins, lotions, creams, etc. in order to have a pill form of the foam type. In order to have effervescent properties, the water-soluble active ingredient is blended in the range of 1.0 to 60.0% by weight, preferably 10.0 to 40.0% by weight, based on the total weight. Sodium carbonate or sodium bicarbonate is formulated in the range of 5.0 to 70.0% by weight, preferably 20.0 to 40.0% by weight relative to the total weight, and alpha hydroxy acid is 1.0 to 70.0% by weight, preferably 20.0 to 40.0 relative to the total weight Compound in the range by weight. In order to form a pill, polyethylene glycol is added as a binder in a range of 5.0 to 30.0% by weight, preferably 10 to 20% by weight, based on the total weight.

이하 본 발명에 따른 발포형 알약 형태의 무수 제형의 화장료 조성물의 구성 및 이의 제조방법에 관한 것을 실시예 및 시험예에 의거하여 보다 구체적으로 설명한다. 그러나 본 발명이 이들 실시예에 한정되는 것은 아니다. Hereinafter, the configuration of the cosmetic composition of the anhydrous dosage form in the form of an expanded tablet according to the present invention, and a method for preparing the same will be described in more detail with reference to Examples and Test Examples. However, the present invention is not limited to these examples.

[실시예 1~2 및 비교예 1~2] 발포형 입자의 제조[Examples 1 and 2 and Comparative Examples 1 and 2] Preparation of Foamed Particles

아래의 제형들은 모두 다 무수 제형이다. The formulations below are all anhydrous.

원료명(함량: 중량%)Raw material name (content: weight%) 실시예1Example 1 실시예2Example 2 비교예1Comparative Example 1 비교예2Comparative Example 2 소듐 카보네이트(sodium carbonate)Sodium carbonate 30.030.0 -- -- -- 소듐 바이카보네이트 (sodium bicarbonate)Sodium bicarbonate 35.035.0 -- -- 말릭산(malic acid)Malic acid 26.026.0 31.031.0 -- -- 폴리에틸렌글리콜(PEG 150)Polyethylene Glycol (PEG 150) 12.012.0 12.012.0 -- 1212 비타민 C(ascorbic acid)Vitamin C (ascorbic acid) 10.010.0 10.010.0 1010 1010 알부틴(arbutin)Arbutin 20.020.0 10.010.0 2020 1010 베타인(betaine)Betaine 1.01.0 1.01.0 3030 3333 트레할로스(trehalose)Trehalose 1.01.0 1.01.0 4040 3535

<실시예 1~2 제조 방법> <Examples 1 and 2 Manufacturing Method>

(1) 고형성분들을 균일하게 혼합한다. 단, 말릭산은 제일 나중에 투입하여 혼합한다. (1) The solid components are mixed uniformly. However, malic acid is added last and mixed.

(2) 상기 (1)을 뜨거운 바람에 노출시키거나 오븐에서 가온하여 남아 있는 수분을 제거한다. (2) Expose (1) to hot wind or warm in oven to remove any remaining moisture.

(3) 상기 (2)를 성형기에 넣어서 원하는 형태와 원하는 중량으로 찍어내서 발포형 필 입자를 얻는다. (3) The above (2) is put into a molding machine, and dipping into desired shapes and desired weights to obtain foamed fill particles.

<비교예 1~2 제조 방법> <Comparative Examples 1-2 Manufacturing Method>

(1) 고형성분을 균일하게 혼합한다. (1) The solid components are mixed uniformly.

(2) 상기 (1)을 뜨거운 바람에 노출시키거나 오븐에서 가온하여 남아 있는 수분을 제거한다. (2) Expose (1) to hot wind or warm in oven to remove any remaining moisture.

(3) 상기 (2)를 믹서와 같은 것으로 분쇄하여 미립자 상태로 얻는다. (3) The said (2) is grind | pulverized with the same thing as a mixer, and is obtained in a particulate state.

[참고예] 유액의 제조Reference Example Preparation of Latex

아래는 가용화 유액 제형이다. Below is a solubilized emulsion formulation.

수상 파트 Award part 정제수Purified water To 100To 100 글리세린glycerin 1.01.0 부틸렌글리콜Butylene glycol 1.01.0 디소디움 이디티에이 (Disodium EDTA)Disodium EDTA 0.020.02 알코올 파트 Alcohol parts 에탄올ethanol 4.04.0 방부제antiseptic 0.30.3 캐스터오일 (PEG-60 Hydrogenated Castor Oil)Castor Oil (PEG-60 Hydrogenated Castor Oil) 0.30.3 incense 0.10.1

<유액 제조방법> <Oil preparation method>

(1) 알코올파트에서 에탄올에 나머지 3가지 성분을 넣어서 가온(40∼45℃)하여 용해시킨다. (1) In the alcohol part, add the remaining three components to ethanol and warm it (40-45 ℃) to dissolve it.

(2) 수상파트를 균일하게 혼합하고, 용해시킨다. (2) The water phase parts are mixed uniformly and dissolved.

(3) 상기 (1)을 (2)에 교반 하에 서서히 투입하여 유액을 얻는다. (3) The said (1) is gradually added to (2) under stirring, and an emulsion is obtained.

<시험예 1><Test Example 1>

실시예 1과 2, 비교예 1과 2에서 제조된 것을 유액에 넣어서 버블링 현상의 유무를 관찰하였다. 실시예 1과 2는 0.4g의 원기둥 모양의 알약 형태로 만든 것을 이용하였다. 실시예 1과 2, 비교예 1과 2 모두 질량기준으로 0.4g을 3.6g의 유액에 넣어서 관찰하였으며, 그 결과를 <표 1>에 나타내었다. The prepared in Examples 1 and 2, Comparative Examples 1 and 2 was put into the emulsion to observe the presence of bubbling phenomenon. Examples 1 and 2 were used in the form of 0.4g cylindrical pills. In Examples 1 and 2 and Comparative Examples 1 and 2, 0.4g was added to 3.6g of an emulsion on a mass basis, and the results are shown in <Table 1>.

관찰 항목Observation item 실시예1Example 1 실시예2Example 2 비교예1Comparative Example 1 비교예2Comparative Example 2 버블링 현상Bubbling phenomenon OO OO X X X X O: 있다, X: 없다O: Yes, X: No

상기 <표 1>에서 보는 바와 같이, 실시예 1과 2에서는 버블링 현상이 있음을 관찰할 수 있었으나, 비교예 1과 2에서는 버블링 현상을 관찰할 수 없었다. 이 결과로 버블링 현상은 소듐 카보네이트 또는 소듐 바이카보네이트와 말릭산이 있음으로써 일어남을 알 수 있다. As shown in Table 1, it was observed that in Examples 1 and 2 there was a bubbling phenomenon, but in Comparative Examples 1 and 2 it was not possible to observe the bubbling phenomenon. As a result, the bubbling phenomenon can be seen to occur due to the presence of sodium carbonate or sodium bicarbonate and malic acid.

<시험예 2><Test Example 2>

시험예 2에서는 용해시간 및 용해 후 잔존물의 유무 정도를 관찰하였다. 시험예 1에서와 마찬가지로 실시예 1과 2는 0.4g의 원기둥 모양의 알약 형태로 만든 것을 이용하였다. 실시예 1과 2, 비교예 1과 2 모두 질량기준으로 0.4g을 3.6g의 유액에 넣어서 관찰하였으며, 그 결과를 <표 2>에 나타내었다. 실시예 1과 2는 유액에 투입한 채 가만히 둔 상태로 관찰하였고, 비교예 1과 2는 천천히 아래위로 손으로 흔들어서 용해가 다 된 후 관찰하였다. In Test Example 2, the dissolution time and the degree of residue after dissolution were observed. As in Test Example 1, Examples 1 and 2 were used in the form of 0.4g cylindrical pills. In Examples 1 and 2 and Comparative Examples 1 and 2, 0.4g was added to 3.6g of emulsion on a mass basis, and the results are shown in <Table 2>. Examples 1 and 2 were observed while still in the state while being put into the emulsion, Comparative Examples 1 and 2 were observed by shaking slowly up and down by hand and after dissolution.

관찰 항목Observation item 실시예1Example 1 실시예2Example 2 비교예1Comparative Example 1 비교예2Comparative Example 2 용해시간 또는 용해하기 위해서 흔든 회수Dissolution time or recovery of shaking to dissolve 2분 4초2 minutes 4 seconds 1분 50초1 minute 50 seconds 31회 Episode 31 20회 20 times 용해 후 잔존물 유무Presence of residue after melting XX XX XX XX O: 있다, X: 없다O: Yes, X: No

상기 <표2>로부터 알 수 있듯이 실시예 1과 2는 용해가 저절로 되므로 사용의 편리성이 있으나, 비교예 1과 2는 손으로 직접 흔들어야 하는 불편을 초래함을 알 수 있다. As can be seen from Table 2, Examples 1 and 2 are easy to use because the dissolution is spontaneous, but Comparative Examples 1 and 2 cause inconvenience to shake by hand.

비교예 1과 2와 실시예 1과 2 모두 용해 후 잔존물은 없음을 알 수 있다. 그러나, 이것은 비교예 1과 2의 경우 완전히 용해 될 때까지 흔들어 주어야 한다는 전제조건 하에서 가능한 것임을 알 수 있다. It can be seen that in Comparative Examples 1 and 2 and Examples 1 and 2, there is no residue after dissolution. However, it can be seen that this is possible under the precondition that in the case of Comparative Examples 1 and 2 should be shaken until completely dissolved.

<시험예 3><Test Example 3>

이번에는 유효성분의 농도를 높여서 실험을 해보았다. 실시예 1을 0.2g의 원기둥 모양의 알약 형태로 만든 것을 이용하였다. 질량기준으로 0.2g의 알약을 1개에서 2개, 3개로 개수를 늘려서 각각 3.6g의 유액에 넣고 관찰하였으며, 그 결과는 <표 3>에 나타내었다. This time, the experiment was performed by increasing the concentration of the active ingredient. Example 1 was used in the form of a 0.2g cylindrical pill. The 0.2g tablets were added to one and two and three tablets by mass, respectively, and placed in 3.6g of latex, and the results are shown in <Table 3>.

관찰 항목 Observation item 실시예 1 알약 개수Example 1 Tablet Count 1개One 2개2 3개Three 용해시간Dissolution time 2분 1초2 minutes 1 second 1분 59초1 minute 59 seconds 2분5초2 minutes 5 seconds 용해후 잔존물 유무Presence of residue after dissolution XX XX XX O: 있다, X: 없다O: Yes, X: No

상기 <표 3>에서 보는 바와 같이, 실시예 1의 개수를 1개에서 3개까지 늘려서 관찰한 결과 용해되는 시간의 차이는 거의 없었으며, 용해 후 잔존물도 없음을 확인할 수 있다. 따라서 유효성분의 농도를 높이고자 원할 때는 단순히 알약의 개수를 늘림으로써 가능하며 용해시간이 더 길어지거나 잔존물이 남는 문제점은 없음을 알 수 있다. As shown in Table 3, the number of Example 1 was increased from one to three, and as a result, there was almost no difference in time of dissolution and no residue after dissolution. Therefore, when you want to increase the concentration of the active ingredient is possible by simply increasing the number of pills, it can be seen that there is no problem of longer dissolution time or residues.

<시험예 4> <Test Example 4>

이번에는 화장료 조성물의 사용시의 편리성 및 시각적 차별화가 있는지 알아보기 위하여 25명의 시험 대상자들로 하여금 시각적 차별화 및 사용의 편리성 품평을 실시하였으며, 시각적 차별화에 대한 결과는 <표 4>에, 사용의 편리성에 대한 결과는 <표 5>에 나타내었다. 실시예 1은 0.4g의 원기둥 모양의 알약 형태로 만든 것을 이용하였으며, 실시예 1, 비교예 1 모두 질량기준으로 0.4g을 3.6g의 유액에 넣어서 사용한 후 설문조사 하였다. 평가는 상대 평가를 하게 하였다. This time, 25 test subjects performed visual differentiation and ease of use to evaluate the convenience and visual differentiation of the cosmetic composition. The results of visual differentiation are shown in <Table 4>. Results for convenience are shown in Table 5. Example 1 was used in the form of 0.4g cylindrical pill, and Example 1, Comparative Example 1 was used after putting 0.4g in 3.6g of milk based on the mass basis, and then surveyed. Evaluation made relative evaluation.

관찰 항목 Observation item 응답수(명)Responses 실시예1Example 1 비교예1Comparative Example 1 시각적 차별화 있다There is visual differentiation 2525 00 모르겠다, 무응답I don't know, no response 00 00

관찰 항목 Observation item 응답수(명)Responses 실시예1Example 1 비교예1Comparative Example 1 편리하다It is convenient 2323 00 모르겠다, 무응답I don't know, no response 00 22

상기 <표4> 및 <표 5>에서 알 수 있듯이, 실시예 1이 편리하다는 응답이 92%, 시각적 차별화가 있다는 응답이 100%로 나왔다. 이 설문 결과로 버블링 필 타입의 실시예 1의 경우가 사용하기에 편리하고 시각적 차별화가 있다는 점을 확인할 수 있었다. As can be seen from Tables 4 and 5, 92% of the convenience of Example 1 was found to be 100%, and there was a visual differentiation. As a result of this questionnaire, it can be seen that the case of Example 1 of the bubbling peel type is convenient to use and has visual differentiation.

이상에서 설명한 바와 같이, 소듐 카보네이트(sodium carbonate)와 알파 하이드록시산(α-hydroxy acid), 그리고 폴리에틸렌글리콜을 이용함으로써 발포형(버블링) 알약(필) 형태의 무수 제형의 화장료 조성물의 제조가 가능하고, 그에 따라 발포형 알약을 유액에 넣음으로써 기포가 발생하여 이른바 버블링 현상을 가지는 발포형 알약(버블링 필)을 제조할 수 있다. 발포형 알약(버블링 필)은 수분이 없는 입자형태로서 불안정한 수용성 활성성분의 안정화를 도모할 수 있다. 더불어 버블링 현상에 의해서 시각적으로 소비자에게 버블링 필내에 함유되어 있는 수용성 활성성분의 용해시점을 알려줄 뿐만 아니라, 시각적 차별화가 가능한 제품이 될 수 있음을 알 수 있다. 간단한 알약(필)의 형태로 만들어져 있어서 알약(필)의 개수를 조절함으로써 유액내의 활성 성분의 농도를 조절이 가능해짐으로써 소비자가 스스로 사용할 수 있는 농도 범위를 넓혀 주는 이점도 가지고 있음을 알 수 있다. As described above, the preparation of the cosmetic composition in anhydrous form in the form of an effervescent (bubbling) pill (fill) by using sodium carbonate, alpha hydroxy acid, and polyethylene glycol It is possible to produce a foamed pill (bubbling pill) having a so-called bubbling phenomenon by generating bubbles by pouring the foamed pill into the milk accordingly. Foamed pills (bubbling pills) are capable of stabilizing unstable water-soluble active ingredients in the form of particles without moisture. In addition, the bubbling phenomenon not only visually informs the point of dissolution of the water-soluble active ingredient contained in the bubbling pill, but also shows that the product can be visually differentiated. Since it is made in the form of a simple pill (pill), it is possible to control the concentration of the active ingredient in the emulsion by controlling the number of pills (pill), it can be seen that it also has the advantage of widening the concentration range that consumers can use themselves.

Claims (4)

수용성 활성성분; 소듐 카보네이트(sodium carbonate) 또는 소듐 바이카보네이트(sodium bicarbonate); 알파 하이드록시산(α-hydroxy acid); 및 폴리에틸렌글리콜을 함유하여 발포 성질을 가지는 알약 형태의 무수 제형 화장료 조성물. Water-soluble active ingredient; Sodium carbonate or sodium bicarbonate; Alpha hydroxy acid; And an anhydrous formulation cosmetic composition in pill form containing polyethylene glycol and having foaming properties. 제 1항에 있어서, 상기 수용성 활성성분은 1.0~60.0 중량%, 소듐 카보네이트(sodium carbonate) 또는 소듐 바이카보네이트(sodium bicarbonate)는 5.0∼70.0 중량%, 알파 하이드록시산(α-hydroxy acid)은 1.0∼70.0 중량%, 폴리에틸렌글리콜은 5.0∼30.0 중량%를 함유하는 것을 특징으로 하는 화장료 조성물. According to claim 1, wherein the water-soluble active ingredient is 1.0 to 60.0% by weight, sodium carbonate (sodium carbonate) or sodium bicarbonate (sodium bicarbonate) is 5.0 to 70.0% by weight, alpha hydroxy acid (α-hydroxy acid) is 1.0 -70.0 weight%, polyethyleneglycol contains 5.0-30.0 weight%, The cosmetic composition characterized by the above-mentioned. 제 1항 또는 제 2항에 있어서, 상기 수용성 활성성분은 비타민C(ascorbic acid), 코지산(kojic acid), 알부틴(arbutin), 니아신아미드(niacinamide) 및 아세틸글루코스아민(acetyl glucosamine)으로 이루어진 군에서 선택되는 1종 이상인 것을 특징으로 하는 화장료 조성물.According to claim 1 or 2, wherein the water-soluble active ingredient is a group consisting of vitamin C (ascorbic acid), kojic acid (kojic acid), arbutin (arbutin), niacinamide (acetylcinamide) and acetyl glucosamine (acetyl glucosamine) Cosmetic composition, characterized in that at least one selected from. 제 1항 또는 제 2항에 있어서, 상기 알파 하이드록시산은 말릭산(malic acid), 락틱산(lactic acid), 글리콜릭산(glycolic acid) 및 시트릭산(citric acid)으로 이루어진 군에서 선택된 것임을 특징으로 하는 화장료.The method of claim 1 or 2, wherein the alpha hydroxy acid is selected from the group consisting of malic acid (lactic acid), lactic acid (lactic acid), glycolic acid (glycolic acid) and citric acid (citric acid) Cosmetics.
KR1020060105078A 2006-10-27 2006-10-27 Non hydrous cosmetic compositions of bubbling pill type containing hydrophilic active ingredients KR101230934B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020060105078A KR101230934B1 (en) 2006-10-27 2006-10-27 Non hydrous cosmetic compositions of bubbling pill type containing hydrophilic active ingredients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020060105078A KR101230934B1 (en) 2006-10-27 2006-10-27 Non hydrous cosmetic compositions of bubbling pill type containing hydrophilic active ingredients

Publications (2)

Publication Number Publication Date
KR20080037857A true KR20080037857A (en) 2008-05-02
KR101230934B1 KR101230934B1 (en) 2013-02-07

Family

ID=39646741

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020060105078A KR101230934B1 (en) 2006-10-27 2006-10-27 Non hydrous cosmetic compositions of bubbling pill type containing hydrophilic active ingredients

Country Status (1)

Country Link
KR (1) KR101230934B1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014193076A1 (en) * 2013-05-30 2014-12-04 (주)아모레퍼시픽 Cosmetic kit comprising effervescent tablet and skin toner
KR101511253B1 (en) * 2008-07-31 2015-04-10 주식회사 엘지생활건강 Composition comprising pure vitamin c for whitening
JP5760280B1 (en) * 2014-05-12 2015-08-05 株式会社東洋新薬 Effervescent skin external preparation
WO2021132783A1 (en) * 2019-12-27 2021-07-01 요시모토알앤디가부시키가이샤 Foamable cosmetic

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101685393B1 (en) 2015-04-17 2016-12-13 주식회사 호스크 Baby bottle disinfectant manufacturing method
KR102036801B1 (en) * 2019-01-29 2019-10-25 주식회사 골든스트릿 Package for mask pack

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19757059A1 (en) * 1997-12-20 1999-07-01 Merz & Co Gmbh & Co Balneological products combining properties of effervescent tablets and liquid or oil bath

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101511253B1 (en) * 2008-07-31 2015-04-10 주식회사 엘지생활건강 Composition comprising pure vitamin c for whitening
WO2014193076A1 (en) * 2013-05-30 2014-12-04 (주)아모레퍼시픽 Cosmetic kit comprising effervescent tablet and skin toner
KR20140140847A (en) * 2013-05-30 2014-12-10 (주)아모레퍼시픽 Cosmetic kit containing bubbling tablet and skin water
US9687430B2 (en) 2013-05-30 2017-06-27 Amorepacific Corporation Cosmetic kit comprising effervescent tablet and skin toner
JP5760280B1 (en) * 2014-05-12 2015-08-05 株式会社東洋新薬 Effervescent skin external preparation
WO2021132783A1 (en) * 2019-12-27 2021-07-01 요시모토알앤디가부시키가이샤 Foamable cosmetic

Also Published As

Publication number Publication date
KR101230934B1 (en) 2013-02-07

Similar Documents

Publication Publication Date Title
KR101230934B1 (en) Non hydrous cosmetic compositions of bubbling pill type containing hydrophilic active ingredients
KR100736667B1 (en) Transparent bar soap composition
KR101663141B1 (en) Cosmetic compositions having skin moisturizing containing capsule, and method for producing the same
EP3610851B1 (en) Skin cleanser composition
KR20160043758A (en) High moisturizing and mild cosmetic composition for washing
KR20160117111A (en) Cosmetic composition containing a plant-derived emulsifying agent
KR102506124B1 (en) cosmetic composition having excellent stabilizing poorly soluble materials and skin permeability
EP3610848A1 (en) Skin cleanser composition
KR20180020664A (en) 2 component type cosmetic composition
EP3610847B1 (en) Skin cleanser composition
KR20180087034A (en) Cosmetic composition comprising polyglyceryl based surfactant
JP2018027907A (en) Oil foam aerosol composition
KR20110084053A (en) Two-layer cleanser cosmetic composition having moisturizing effect and manufacturing method thereof
KR101741981B1 (en) Aerosol cosmetic composition of leave on type
US9572755B2 (en) Bath salt composition
JP6543454B2 (en) Hair cosmetic composition and hair treatment method
KR20120039396A (en) Cosmetic composition containing fluorine compounds and method for preparing the same
KR101783338B1 (en) Aerosol-type foamy oxidative hair dye composition
KR102034142B1 (en) Emulsion composition containing polysilsesquioxane and emollient effective for skin moisturizing and wrinkle relief and cosmetic composition using the same
KR102065321B1 (en) Oil-in-water emulsion composition containing recrystallized particle and cosmetic composition comprising the same
KR102571190B1 (en) Cleansing balm composition and manufacturing method thereof
KR102537030B1 (en) Composition comprising titrated extract of Cetella asiatica for UV protection
KR20190099208A (en) Stick-like skin external solid base material
KR102211754B1 (en) Elongational cosmetic composition with shape restoration ability and manufacturing method thereof
JP7150050B2 (en) skin cleanser composition

Legal Events

Date Code Title Description
N231 Notification of change of applicant
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20161228

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20190102

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20200102

Year of fee payment: 8